CTSO
Price:
$0.4383
Market Cap:
$27.52M
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology. The company's leading product, CytoSorb, is an extracorporeal filter designed to remove cytokines from the blood. It serves as a complementary treatment in various critical care scenarios, including sepsis, managing complications during and after heart bypass surgery, and improving the viability of donor organs for transplantation. Beyond CytoSorb, Cytosorbents offers a portfolio of specialized devices. These include VetResQ, used to assist in treating critical c...[Read more]
Industry
Medical - Devices
IPO Date
2006-08-08
Stock Exchange
NASDAQ
Ticker
CTSO
According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -2.43. This represents a change of -580.49% compared to the average of 0.51 of the last 4 quarters.
The mean historical PE Ratio of Cytosorbents Corporation over the last ten years is -11.17. The current -2.43 PE Ratio has changed 2.08% with respect to the historical average. Over the past ten years (40 quarters), CTSO's PE Ratio was at its highest in in the June 2025 quarter at 10.29. The PE Ratio was at its lowest in in the December 2020 quarter at -122.24.
Average
-11.17
Median
-6.88
Minimum
-39.85
Maximum
-1.71
Discovering the peaks and valleys of Cytosorbents Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 521.04%
Maximum Annual PE Ratio = -1.71
Minimum Annual Increase = -81.55%
Minimum Annual PE Ratio = -39.85
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.92 | 105.32% |
| 2024 | -2.39 | 40.23% |
| 2023 | -1.71 | -17.37% |
| 2022 | -2.07 | -71.89% |
| 2021 | -7.35 | -81.55% |
| 2020 | -39.85 | 521.04% |
| 2019 | -6.42 | -55.53% |
| 2018 | -14.43 | -31.19% |
| 2017 | -20.97 | 80.82% |
| 2016 | -11.60 | -31.30% |
The current PE Ratio of Cytosorbents Corporation (CTSO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.01
5-year avg
-3.69
10-year avg
-11.17
Cytosorbents Corporation’s PE Ratio is less than IceCure Medical Ltd (-0.77), less than TELA Bio, Inc. (-1.01), greater than Spectral AI, Inc. (-3.44), greater than Sensus Healthcare, Inc. (-5.92), greater than NeuroOne Medical Technologies Corporation (-3.78), less than Baird Medical Investment Holdings Limited (-1.13), greater than electroCore, Inc. (-4.65), greater than Telomir Pharmaceuticals, Inc. Common Stock (-4.83), greater than Biodesix, Inc. (-4.14), less than Serina Therapeutics, Inc. (-1.07),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.77 | $12.16M | |
| -1.01 | $35.86M | |
| -3.44 | $57.92M | |
| -5.92 | $45.93M | |
| -3.78 | $28.63M | |
| -1.13 | $45.49M | |
| -4.65 | $69.89M | |
| -4.83 | $48.82M | |
| -4.14 | $136.84M | |
| -1.07 | $22.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cytosorbents Corporation's PE Ratio?
How is the PE Ratio calculated for Cytosorbents Corporation (CTSO)?
What is the highest PE Ratio for Cytosorbents Corporation (CTSO)?
What is the 3-year average PE Ratio for Cytosorbents Corporation (CTSO)?
What is the 5-year average PE Ratio for Cytosorbents Corporation (CTSO)?
How does the current PE Ratio for Cytosorbents Corporation (CTSO) compare to its historical average?